Cephalosporins are one of the largest and most diverse family of antibiotics of the bactericidal β-lactam group. Based on their antimicrobial activity, they are grouped into various type of generations. Cephalosporin inhibits enzymes in the cell wall of susceptible bacteria, hence disrupting cell synthesis. Increasing research and development activities, and increasing demand for antibacterial drugs is propelling the growth of cephalosporin market.
The market for cephalosporin would continue to rise immensely with the aging population and increasing incidences of infectious diseases worldwide. Cephalosporin have a broad range of therapeutic application and are effective in the treatment of streptococcal, pneumococcal, staphylococcal, Klebsiella, Escherichia coli and Proteus infections. One of the significant roles of cephalosporin has been as chemoprophylactic agents at the time of surgical procedures. In addition, cephalosporin has the ability to retain excellent pharmacokinetic properties, hence making cephalosporin drugs as the first choice for treatment of various infections. However, factors such as certain side-effects associated with cephalosporin and development of drug-resistant bacterial strains might restrain the growth of cephalosporin market.
Market Classification and Overview
The cephalosporin market is segmented on the basis of generation, route of administration, type, application and geography. Based on route of administration, the market is segmented into oral and injection. The injection route of administration is anticipated to grow swiftly during the forecast period owing to its ease-of-use, and better patient compliance.
Based on application, the global market has been bifurcated into sexually transmitted infection, respiratory tract infection, skin infection, ear infection, and urinary tract infection. Sexually transmitted infection dominated the application segment in 2016. Factors such as increasing number of people suffering from sexually transmitted diseases, and excellent efficacy of cephalosporin as antibiotics are driving the market growth. According to the WHO, more than 1 million sexually transmitted infections are acquired each day worldwide.
Regionally, the market for cephalosporin is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa (MEA). North America is dominating the global market owing to the presence of highly advanced healthcare facilities, and presence of large number of patient population affected with sexually transmitted diseases. However, Asia-Pacific is expected to grow at the fastest CAGR due to increased population base, growing disposable income in countries like China and India, and beneficial government initiatives.
2015 – 2026
2015 – 2016
2018 – 2026
Generation, Route of Administration, Type, Application, Geography
North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)
Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,
Player Profiling, Value Chain Analysis
F. Hoffmann-La Roche Ltd., Lupin Limited, Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly and Company, Allergan Plc, GlaxoSmithKline Plc, Merck & Co., Inc., Sanofi, and Teva Pharmaceutical Industries Ltd. are the key players in the cephalosporin market. These players have undertaken mergers and acquisitions as one of their key strategies in order to maximize their share in the global market.
Market By Generation
· First Generation
· Second Generation
· Third Generation
· Fourth Generation
· Fifth Generation
Market By Route of Administration
Market By Type
Market By Application
· Sexually Transmitted Infection
· Respiratory Tract Infection
· Skin Infection
· Ear Infection
· Urinary Tract Infection
Market By Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Introduction Diagnostic ultrasound is an ultrasound application based method. Diagnostic ultrasound technique is used to create an image of structures of internal body such as muscles, blood vessels, tendons, joints and other internal organs. Its aim is to exclude pathology or find a source of a disease. Diagnostic ultrasound is also used for examining pregnant women. The report provides analysis of global
Introduction Breast implants are medical devices that are used to enlarge the size of breasts either for cosmetic applications or rebuilding purpose. Breast expansion, generally called as breast enlargement, is a popular surgical method that enhances the shape and size of the breast. This method includes the use of breast implants in order to improve the size of the breasts. In clinical terms, breast expan
Introduction The global urology devices Market is projected worth US$57.4 billion by 2026 and the market is projected to showcase 6.9% CAGR during the forecast period. The urology devices market is driven by the easy availability of urology devices and high occurrence of urology disorder associated with the urinary tract system (UTS) across the globe.
Introduction The global pet cancer therapeutics Market is projected worth US$345.2 million by 2026 and the market is projected to showcase 10.6% CAGR during the forecast period. The pet cancer therapeutics market is driven by the rapid adoption of innovative pet care medicines. Market Dynamics
Introduction The global oxygen cylinders & concentrators Market is projected worth US$5,320.4 million by 2026 and the market is projected to showcase 9.1% CAGR during the forecast period. The oxygen cylinders & concentrators market is driven by an increase in the old age population in developing economies. Market
Introduction The global invisible orthodontics market’s value is expected to reach USD 6,609.40 million by the end of 2026 and the market is anticipated to markets a CAGR of 15.2% through the coming years. The market growth is determined by occurrence of malocclusion internationally. Market Dynamics